Kaila Aguiar Soares, Joanna Ehrlich, Miguel Camará, Souleymane Chaloub, Elom Emeka, Hervé Gildas Gando, Farzana Ismail, Lindiwe Mvusi, Thulani Jele, Benedita José, Botshelo Kgwaadira, Riziki Kisonga, Taye Letta, Aubin Oyongo Liega, Patrick Saili Lungu, Llang Maama, Jocelyn Mahoumbou, Kuzani Mbendera, Jeremiah Ogoro, Daniel Alphonse Désiré Tollo, Charles Sandy, Rufus G. Saye, Jacob Sheehama, Sissy Musala, Didas Tugumisirize, Lucia Carratala, Marta Cossa, Alberto L. Garcia-Basteiro

European Respiratory Journal 2023; DOI: 10.1183/13993003.00556-2023

Extract

Despite disruptions caused by the COVID-19 pandemic, tuberculosis (TB) is still one of the top causes of death from an infectious disease, killing over 1.6 million people worldwide every year [1]. TB is curable with prompt detection and appropriate treatment, but it is estimated that over 30% of TB cases go undiagnosed annually [1]. Early diagnosis is crucial for optimal TB outcomes, especially among those most vulnerable to the disease such as people living with HIV (PLHIV), who experience higher rates of death from TB than those who are HIV negative [1].